The pharmaceutical world is witnessing a remarkable shift in blood sugar treatment with the emergence of GLP-1 transdermal devices. These devices offer a potentially more user-friendly alternative to shots of GLP-1 drugs, lessening the requirement of daily needle pokes. The innovation delivers th